These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22833571)

  • 21. Budget allocation and the revealed social rate of time preference for health.
    Paulden M; Claxton K
    Health Econ; 2012 May; 21(5):612-8. PubMed ID: 21438069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
    Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
    Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choosing between competing health priorities. A government payer perspective.
    Leese J
    Pharmacoeconomics; 1996; 9 Suppl 3():4-7; discussion 23-5. PubMed ID: 10160486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eliciting stated preferences for health-technology adoption criteria using paired comparisons and recommendation judgments.
    Johnson FR; Backhouse M
    Value Health; 2006; 9(5):303-11. PubMed ID: 16961548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?
    Duthie T; Trueman P; Chancellor J; Diez L
    Health Policy; 1999 Jan; 46(2):143-57. PubMed ID: 10346286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J; Weehuizen R; Mavranezouli I; Mihalopoulos C; Smit F
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary care and health care reform: the need to reflect before reforming.
    Maynard A; Bloor K
    Health Policy; 1995 Mar; 31(3):171-81. PubMed ID: 10142614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health economic assessment: a methodological primer.
    Simoens S
    Int J Environ Res Public Health; 2009 Dec; 6(12):2950-66. PubMed ID: 20049237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using economic evidence to support decision making: a case study of assertive community treatment within the UK National Service Framework for Mental Health.
    Nixon J; Phipps K; Glanville J; Mugford M; Drummond M
    Appl Health Econ Health Policy; 2002; 1(4):179-90. PubMed ID: 14619247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal coverage and cost control: the United Kingdom National Health Service.
    Maynard A; Bloor K
    J Health Hum Serv Adm; 1998; 20(4):423-41. PubMed ID: 10338720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the usefulness of budget impact analyses: a U.S. payer perspective.
    Watkins JB; Danielson D
    Value Health; 2014; 17(1):3-4. PubMed ID: 24438711
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group.
    Hoffmann C; Graf von der Schulenburg JM
    Health Policy; 2000 Jul; 52(3):179-92. PubMed ID: 10862993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand.
    Teerawattananon Y; Russell S
    Value Health; 2008 Mar; 11 Suppl 1():S52-60. PubMed ID: 18387068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based medicine as an instrument for rational health policy.
    Biller-Andorno N; Lie RK; ter Meulen R
    Health Care Anal; 2002; 10(3):261-75. PubMed ID: 12769414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effective but unaffordable: an emerging challenge for health systems.
    Charlton V; Littlejohns P; Kieslich K; Mitchell P; Rumbold B; Weale A; Wilson J; Rid A
    BMJ; 2017 Mar; 356():j1402. PubMed ID: 28330879
    [No Abstract]   [Full Text] [Related]  

  • 39. The development of funding recommendations for health technologies at the state level: A South Australian case study.
    Lambert R; Carter D; Burgess N; Haji Ali Afzali H
    Int J Health Plann Manage; 2018 Oct; 33(4):806-822. PubMed ID: 29676055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality assessment of health economic evaluation.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.